|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.29 USD | -1.94% |
|
-2.72% | -0.60% |
| 12-04 | Chewy Insider Sold Shares Worth $501,774, According to a Recent SEC Filing | MT |
| 12-03 | UBS Adjusts Chewy Price Target to $41 From $43, Maintains Neutral Rating | MT |
| Fiscal Period: February | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -4.23 | -2.36 | 1.51 | -0.52 | 2.27 | |||||
Return on Total Capital | -71.88 | -11.36 | 6 | -1.71 | 7.55 | |||||
Return On Equity % | 45.56 | -1.16K | 43.06 | 11.81 | 101.78 | |||||
Return on Common Equity | 45.56 | -1.16K | 43.06 | 11.81 | 101.78 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 25.48 | 26.7 | 28.03 | 28.36 | 29.24 | |||||
SG&A Margin | 26.74 | 27.51 | 27.48 | 28.57 | 28.29 | |||||
EBITDA Margin % | -0.87 | -0.35 | 1.16 | 0.5 | 1.6 | |||||
EBITA Margin % | -1.27 | -0.81 | 0.55 | -0.21 | 0.95 | |||||
EBIT Margin % | -1.27 | -0.81 | 0.55 | -0.21 | 0.95 | |||||
Income From Continuing Operations Margin % | -1.29 | -0.83 | 0.49 | 0.36 | 3.31 | |||||
Net Income Margin % | -1.29 | -0.83 | 0.49 | 0.36 | 3.31 | |||||
Net Avail. For Common Margin % | -1.29 | -0.83 | 0.49 | 0.36 | 3.31 | |||||
Normalized Net Income Margin | -0.81 | -0.52 | 0.32 | 0.27 | 0.8 | |||||
Levered Free Cash Flow Margin | -0.01 | 1.07 | 0.43 | 3.11 | 2.87 | |||||
Unlevered Free Cash Flow Margin | 0.01 | 1.08 | 0.44 | 3.13 | 2.9 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 5.35 | 4.65 | 4.39 | 3.91 | 3.83 | |||||
Fixed Assets Turnover | 18.9 | 14.26 | 12.3 | 11.74 | 13.12 | |||||
Receivables Turnover (Average Receivables) | 78.89 | 79.31 | 80.84 | 79.34 | 73.43 | |||||
Inventory Turnover (Average Inventory) | 12.82 | 12.14 | 11.76 | 11.43 | 10.79 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.89 | 0.8 | 0.86 | 1 | 0.75 | |||||
Quick Ratio | 0.48 | 0.44 | 0.45 | 0.63 | 0.35 | |||||
Operating Cash Flow to Current Liabilities | 0.1 | 0.12 | 0.2 | 0.23 | 0.27 | |||||
Days Sales Outstanding (Average Receivables) | 4.61 | 4.59 | 4.5 | 4.59 | 5.05 | |||||
Days Outstanding Inventory (Average Inventory) | 28.4 | 29.99 | 30.95 | 31.84 | 34.39 | |||||
Average Days Payable Outstanding | 48.18 | 46.07 | 47.19 | 48.48 | 49.71 | |||||
Cash Conversion Cycle (Average Days) | -15.16 | -11.5 | -11.73 | -12.05 | -10.27 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | -17.33K | 2.95K | 233.4 | 109.12 | 204.97 | |||||
Total Debt / Total Capital | 100.58 | 96.72 | 70.01 | 52.18 | 67.21 | |||||
LT Debt/Equity | -16.38K | 2.78K | 220.5 | 103.44 | 192.15 | |||||
Long-Term Debt / Total Capital | 95.04 | 91.33 | 66.14 | 49.46 | 63.01 | |||||
Total Liabilities / Total Assets | 100.12 | 99.29 | 91.49 | 83.99 | 91.33 | |||||
EBIT / Interest Expense | -44.74 | -44.04 | 21.66 | -6.6 | 20.4 | |||||
EBITDA / Interest Expense | 0 | 29.37 | 80.6 | 44.74 | 53.73 | |||||
(EBITDA - Capex) / Interest Expense | -64.66 | -88.55 | -8.87 | 4.74 | 27.67 | |||||
Total Debt / EBITDA | - | 9.03 | 2.41 | 3.47 | 1.81 | |||||
Net Debt / EBITDA | - | -3.5 | -0.86 | -3.6 | -0.2 | |||||
Total Debt / (EBITDA - Capex) | -2.66 | -2.99 | -21.87 | 32.78 | 3.51 | |||||
Net Debt / (EBITDA - Capex) | 1.65 | 1.16 | 7.8 | -33.98 | -0.4 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 47.44 | 24.41 | 13.59 | 10.17 | 6.4 | |||||
Gross Profit, 1 Yr. Growth % | 59.15 | 30.36 | 19.27 | 11.54 | 9.68 | |||||
EBITDA, 1 Yr. Growth % | -73.04 | -49.57 | -471.9 | -52.44 | 239.27 | |||||
EBITA, 1 Yr. Growth % | -64.2 | -20.21 | -177.24 | -141.87 | -576.56 | |||||
EBIT, 1 Yr. Growth % | -64.2 | -20.21 | -177.24 | -141.87 | -576.56 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -63.35 | -20.19 | -166.69 | -20.68 | 892.26 | |||||
Net Income, 1 Yr. Growth % | -63.35 | -20.19 | -166.69 | -20.68 | 892.26 | |||||
Normalized Net Income, 1 Yr. Growth % | -63.35 | -20.19 | -170.28 | -8.19 | 213.56 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -64.16 | -21.74 | -164.76 | -23.83 | 911.11 | |||||
Accounts Receivable, 1 Yr. Growth % | 25.13 | 22.65 | 2.3 | 21.32 | 9.73 | |||||
Inventory, 1 Yr. Growth % | 61.51 | 9.18 | 20.54 | 6.09 | 16.32 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 66.78 | 45.86 | 21.94 | 10.36 | 0.85 | |||||
Total Assets, 1 Yr. Growth % | 86.73 | 19.84 | 20.55 | 26.47 | -5.41 | |||||
Tangible Book Value, 1 Yr. Growth % | -91.28 | -835.33 | 1.08K | 289.65 | -68.77 | |||||
Common Equity, 1 Yr. Growth % | -99.5 | -835.33 | 1.35K | 218.37 | -48.76 | |||||
Cash From Operations, 1 Yr. Growth % | 185 | 44.43 | 82.32 | 39.01 | 22.65 | |||||
Capital Expenditures, 1 Yr. Growth % | 168.82 | 47.83 | 19.15 | -37.79 | 0.38 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -100.39 | -14.18K | -54.74 | 251.16 | -1.77 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -99.66 | 16.31K | -53.71 | 247.75 | -1.42 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 42.23 | 35.44 | 18.88 | 11.5 | 8.27 | |||||
Gross Profit, 2 Yr. CAGR % | 59.6 | 44.04 | 24.69 | 15.12 | 10.61 | |||||
EBITDA, 2 Yr. CAGR % | -50.11 | -63.12 | 36.95 | 31.22 | 27.03 | |||||
EBITA, 2 Yr. CAGR % | -41.88 | -46.56 | -21.5 | -43.33 | 41.26 | |||||
EBIT, 2 Yr. CAGR % | -41.88 | -46.56 | -21.5 | -43.33 | 41.26 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -41.24 | -45.92 | -27.04 | -27.45 | 180.55 | |||||
Net Income, 2 Yr. CAGR % | -41.24 | -45.92 | -27.04 | -27.45 | 180.55 | |||||
Normalized Net Income, 2 Yr. CAGR % | -41.24 | -45.92 | -25.1 | -19.91 | 69.67 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -42.28 | -46.7 | -28.81 | -29.34 | 177.52 | |||||
Accounts Receivable, 2 Yr. CAGR % | 43.74 | 23.88 | 12.01 | 11.68 | 15.38 | |||||
Inventory, 2 Yr. CAGR % | 52.45 | 32.79 | 14.72 | 13.29 | 11.09 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 139.99 | 61.56 | 33.36 | 16.02 | 0.29 | |||||
Total Assets, 2 Yr. CAGR % | 79.28 | 49.59 | 20.2 | 23.59 | 9.38 | |||||
Tangible Book Value, 2 Yr. CAGR % | -67.51 | -81.23 | 833.18 | 465.24 | -1.56 | |||||
Common Equity, 2 Yr. CAGR % | -92.28 | -80.9 | 933.27 | 488.44 | 27.73 | |||||
Cash From Operations, 2 Yr. CAGR % | 214.58 | 102.89 | 62.27 | 59.24 | 30.57 | |||||
Capital Expenditures, 2 Yr. CAGR % | 72.07 | 99.35 | 32.72 | -13.9 | -20.97 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -92.04 | -25.69 | 648.06 | 91.5 | 85.72 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -92.59 | -25.29 | 771.52 | 90.75 | 85.16 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 50.31 | 36.02 | 27.72 | 15.98 | 9.77 | |||||
Gross Profit, 3 Yr. CAGR % | 70.47 | 49.19 | 35.26 | 20.19 | 13.28 | |||||
EBITDA, 3 Yr. CAGR % | -38.42 | -49.93 | -20.33 | -3.52 | 80.1 | |||||
EBITA, 3 Yr. CAGR % | -31.04 | -35.4 | -39.58 | -36.08 | 15.24 | |||||
EBIT, 3 Yr. CAGR % | -31.04 | -35.4 | -39.58 | -36.08 | 15.24 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -35.08 | -34.93 | -42 | -24.64 | 73.49 | |||||
Net Income, 3 Yr. CAGR % | -35.08 | -34.93 | -42 | -24.64 | 73.49 | |||||
Normalized Net Income, 3 Yr. CAGR % | -30.55 | -34.93 | -40.98 | -19.5 | 26.23 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -56.02 | -35.84 | -43.13 | -26.86 | 71.55 | |||||
Accounts Receivable, 3 Yr. CAGR % | 40.21 | 36.34 | 16.22 | 15.22 | 11.03 | |||||
Inventory, 3 Yr. CAGR % | 45.69 | 36.4 | 28.58 | 11.9 | 14.29 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 99.06 | 108.11 | 47.09 | 25.22 | 7.05 | |||||
Total Assets, 3 Yr. CAGR % | 51.25 | 56.76 | 39.21 | 22.33 | 13.05 | |||||
Tangible Book Value, 3 Yr. CAGR % | -26.41 | -65.06 | -25.28 | 517.04 | 99.55 | |||||
Common Equity, 3 Yr. CAGR % | -71.18 | -64.73 | -19.09 | 533.81 | 160.82 | |||||
Cash From Operations, 3 Yr. CAGR % | 18.52 | 142.68 | 95.78 | 54.14 | 45.97 | |||||
Capital Expenditures, 3 Yr. CAGR % | 48.06 | 63.57 | 67.92 | 3.1 | -9.38 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | - | -3.7 | -37.08 | 666.74 | 53.29 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | - | -3.38 | -36.31 | 740.4 | 53.08 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | - | 43.96 | 36.85 | 25.84 | 19.6 | |||||
Gross Profit, 5 Yr. CAGR % | - | 56.76 | 50.43 | 34.63 | 24.83 | |||||
EBITDA, 5 Yr. CAGR % | - | -28.03 | -15.22 | -25.89 | -3.85 | |||||
EBITA, 5 Yr. CAGR % | - | -15.51 | -27.37 | -38.46 | -14.93 | |||||
EBIT, 5 Yr. CAGR % | - | -15.51 | -27.37 | -38.46 | -14.93 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | - | -15.11 | -31.98 | -31.78 | 9.25 | |||||
Net Income, 5 Yr. CAGR % | - | -15.11 | -31.98 | -31.78 | 9.25 | |||||
Normalized Net Income, 5 Yr. CAGR % | - | -15.11 | -28.42 | -29.03 | -9.73 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | -84.66 | -46.54 | -33.3 | 7.51 | |||||
Accounts Receivable, 5 Yr. CAGR % | - | - | 28.17 | 25.88 | 16 | |||||
Inventory, 5 Yr. CAGR % | - | - | 32.4 | 26.64 | 21.36 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | - | 72 | 64.74 | 26.21 | |||||
Total Assets, 5 Yr. CAGR % | - | - | 37.96 | 42.54 | 26.45 | |||||
Tangible Book Value, 5 Yr. CAGR % | - | - | 13.77 | 6.38 | -22.48 | |||||
Common Equity, 5 Yr. CAGR % | - | - | 20.65 | 8.72 | -8.33 | |||||
Cash From Operations, 5 Yr. CAGR % | - | 11.12 | 34.39 | 105.04 | 66.52 | |||||
Capital Expenditures, 5 Yr. CAGR % | - | 51.53 | 41.72 | 26.54 | 24.22 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | - | - | - | 26.54 | 14.53 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | - | - | 26.68 | 14.76 |
- Stock Market
- Equities
- CHWY Stock
- Financials Chewy, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















